TEST APPROACH Sample Clauses

TEST APPROACH. 3.1 The Contractor shall develop and maintain Test Approaches as listed in paragraph 1.5 of this Part B. The Contractor shall ensure such Test Approaches relate to all Test Activities in the applicable Test Phases and comply with all Test Requirements, DCC Requirements and the description of Test Phases at Appendix 3 to this Schedule 6.2. The Contractor shall ensure all Test Approaches that are Contractor's Test Documents comply with the Test Strategy. The Contractor recognises that Test Approaches developed by the Prime DSP are anticipated to include, as a minimum, details equivalent to those referred to in paragraph 3.4 of this Part. 3.2 The Contractor shall ensure each Test Approach that is a Contractor's Test Document contains a V-model diagram that details the relationship of the design baseline (including Contractor Solution Design Documents and Service Management Framework documents and relevant Communications Hub design documents) to the Test Stages. 3.3 The Contractor shall review and at all times keep up-to-date (in accordance with the process described in paragraph 6 of this Part B of this Schedule 6.2) each Test Approach it was required to develop and maintain in accordance with paragraph 1.5 of this Part B so as to ensure that they are kept fully up-to- date and accurately reflect the then current status of the relevant Testing Activities (including any arrangements in connection with Future Testing Activities) and otherwise continue to comply with the requirements of this Schedule 6.2. 3.4 Each Contractor’s Test Approach shall include, as a minimum, the details set out below in relation to the applicable Test Phase: (a) an overview of the Testing to be undertaken; (b) the start date for the Testing; (c) the Testing procedure, including the type of Test and the scope of the Test in accordance with Appendix 3; (d) the Test objectives; (e) a detailed list of dependencies the Contractor proposes the DCC consider for inclusion as DCC Responsibilities; (f) the Stage Entry Criteria and Stage Exit Criteria for each Test Stage including the number of Test Incidents permitted listed by Test Incident Severity; (g) the intended volume and management of Test Data, and the dates by which any externally provided Test Data are required by the Contractor; (h) the timetable for each Test Phase; (i) procedures for maintaining the Traceability Matrix; (j) the approach to Regression Testing; (k) the names of the relevant representatives from the DCC (if applicabl...
AutoNDA by SimpleDocs
TEST APPROACH. The following approach will be used for this TQAPP: • Evermore Paints and Coatings will identify the performance parameters to be verified and recommend the optimum equipment settings for application and curing. • Standard test panels will be obtained to enable thorough testing of coating performance. • A verification test will be completed to determine the performance of the Formula 5 coating. • A statistically valid test program that efficiently accomplishes the required objectives will then be used to analyze the test results.
TEST APPROACH. 3.1 The Contractor shall develop and maintain Test Approaches as listed in paragraph 1.5 of this Part B. The Contractor shall ensure such Test Approaches relate to all Test Activities in the applicable Test Phases and comply with all Test Requirements, DCC Requirements and the description of Test Phases at Appendix 3 to this Schedule 6.2. The Contractor shall ensure all Test Approaches that are Contractor's Test Documents comply with the Test Strategy.

Related to TEST APPROACH

  • Target Population TREATMENT FOR ADULT (TRA) Target Population

  • Milestone Schedule Please state the status and progress of each Milestone and identify any completed Milestone(s) for the previous calendar quarter.

  • Project Specific Milestones In addition to the milestones stated in Section 212.5 of the Tariff, as applicable, during the term of this ISA, Interconnection Customer shall ensure that it meets each of the following development milestones: 6.1 Substantial Site work completed. On or before December 31, 2020 Interconnection Customer must demonstrate completion of at least 20% of project site construction. At this time, Interconnection Customer must submit to Interconnected Transmission Owner and Transmission Provider initial drawings, certified by a professional engineer, of the Customer Interconnection Facilities. 6.2 Delivery of major electrical equipment. On or before December 31, 2021, Interconnection Customer must demonstrate that all generating units have been delivered to Interconnection Customer’s project site.

  • Positive Test Results In the event an employee tests positive for drug use, the employee will be provided, in writing, notice of their right to explain the test results. The employee may indicate any relevant circumstance, including over the counter or prescription medication taken within the last thirty (30) days, or any other information relevant to the reliability of, or explanation for, a positive test result.

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving (either itself or through the acts of a SUBLICENSEE) the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • MSAA Indicator Technical Specification Document This Agreement shall be interpreted with reference to the MSAA Indicator Technical Specifications document.

  • Development Milestone Payments (i) In addition to the Closing Date Merger Consideration (less the Remaining Option Consideration and Rights Proceeds Amount, if any) and any Net TNF Sales Payments (as defined below), upon the attainment of the development ** Portions of the Exhibit have been omitted and have been filed separately pursuant to an application for confidential treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. milestones set forth below (each, a “Development Milestone”), Parent shall, or shall cause the Surviving Corporation to, [**] after the occurrence of each Development Milestone, deliver to the Paying Agent (for further payment to the holders of Stock Certificates and Stock Agreements outstanding immediately prior to the Effective Time), via wire transfer of immediately available funds, the respective amounts set forth below minus, in each case, the applicable Contingent Consideration Distribution Fee associated therewith and any amount designated by the Stockholders’ Representatives to be placed in the Administrative Expense Account (each, a “Development Milestone Payment” and collectively, the “Development Milestone Payments”): (A) Upon FDA approval of Reslizumab for the treatment of eosinophilic esophagitis, a cash payment of [**]; (B) Upon marketing authorization of Reslizumab for the treatment of eosinophilic esophagitis being granted by the European Commission in accordance with Regulation (EC) No. 726/2004, a cash payment of [**]; (C) If Res 5-0010 Asthma Study Completion has not occurred on or prior to the Closing Date, then upon the occurrence of the Res 5-0010 Asthma Study Completion, a cash payment of $50,000,000 (fifty million dollars) (the “Res 5-0010 Asthma Payment”); (D) Upon FDA approval of Reslizumab for any asthma indication, a cash payment of [**]; (E) Upon marketing authorization of Reslizumab for the treatment of any asthma indication being granted by the European Commission in accordance with Regulation (EC) No. 726/2004, a cash payment of [**]; and (F) Upon FDA approval of an Oral Anti-TNF Product, a cash payment of [**].

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

  • Milestone A principal event specified in the Contract Documents including the Material Completion and Occupancy Date and other events relating to an intermediate completion date or time.

  • Project/Milestones Taxpayer provides refrigerated warehousing and logistic distribution services to clients throughout the United States. In consideration for the Credit, Taxpayer agrees to invest in a new refrigeration and distribution facility in the XxXxxxxxx Park area of Sacramento, California, and hire full-time employees (collectively, the “Project”). Further, Taxpayer agrees to satisfy the milestones as described in Exhibit A (“Milestones”) and must maintain Milestones for a minimum of three (3) taxable years thereafter. In the event Taxpayer employs more than the number of full-time employees, determined on an annual full-time equivalent basis, than required in Exhibit A, for purposes of satisfying the “Minimum Annual Salary of California Full-time Employees Hired” and the “Cumulative Average Annual Salary of California Full-time Employees Hired,” Taxpayer may use the salaries of any of the full-time employees hired within the required time period. For purposes of calculating the “Minimum Annual Salary of California Full-time Employees Hired” and the “Cumulative Average Annual Salary of California Full-time Employees Hired,” the salary of any full-time employee that is not employed by Taxpayer for the entire taxable year shall be annualized. In addition, the salary of any full-time employee hired to fill a vacated position in which a full-time employee was employed during Taxpayer’s Base Year shall be disregarded.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!